Dorlixizumab
Jump to navigation
Jump to search
Dorlixizumab is a chimeric/humanized monoclonal antibody which it is used as an immunosuppresive drug.
 | This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |